A woman reading a book on a yoga mat in a sunlit forest, representing the integration and preparation phase of psychedelic retreats.

Mar 05 | Educational

Frequently Asked Questions about Psychedelic Retreats

When we think about a psychedelic retreat, our minds usually go to the “what-ifs.” We want to know if we are safe, what happens if things get messy, and if we can actually handle what comes up.

Having these questions isn’t a sign that you aren’t ready; it’s a sign that you are being responsible with your own process. Here is the reality of what happens inside the container.

What if I get a bad trip?

People are terrified of having a bad trip. That fear makes sense if you aren’t in the right hands. Usually, when people have “bad trips,” it’s because they were with facilitators who didn’t know how to handle the depth of what was coming up. They were left to deal with it all by themselves.

When the door to your subconscious opens, “emotional memories” often surface. These are old, unprocessed feelings, like crushing pressure or raw terror, that aren’t attached to a visual image. You aren’t “remembering” a scene; you are re-experiencing the feeling itself. If you are alone, this can be re-traumatizing.

But it doesn’t have to be a “bad” trip. We can transform a difficult experience into a worthwhile one. The difference is that you aren’t alone. Instead of staying stuck in your mind trying to analyze the pain, we help you come back into the body. We stay with you, giving you gentleness and letting you know you are safe. When someone is right there with you while you face an old pain, you can finally drop the weight you’ve been carrying for decades.

What if I discover a “hidden memory” that ruins my life?

If a memory like that surfaces, the emotional weight of it has usually already been affecting your life for years. Carrying that hidden weight causes all kinds of symptoms and even health issues. While revealing it is challenging, it allows us to finally work with it. It is difficult, but it is worthwhile because you stop running from something that is already there.

Could this trigger a permanent mental breakdown or schizophrenia?

If you have no family history or predisposition to psychosis, these cases are extremely rare. While we can never say “never,” it is quite safe for the general population. However, if someone is feeling suicidal, we do not recommend a psychedelic experience until they feel more stable.

What if I need to go to the bathroom or if I throw up?

If you need to use the bathroom, your facilitator will help you get there safely. If you throw up, which is very rare with psilocybin but common with Ayahuasca, we simply accept it. It’s part of the process. We surrender to what the body needs to do and let it go.

Can I do this if I’m on antidepressants or other meds?

Safety depends on the specific drug. We have a detailed medication interaction list for psilocybin that you can check. If you are taking a different psychedelic, you should always verify this with your provider first.

How do you handle medical emergencies?

If something were to go wrong with your heart or breathing, we immediately call an ambulance. In our experience, they arrive within about 12 minutes and have a team on-site. We can’t speak for how other facilitators handle this, but for us, medical access is a priority.

What if it has no effect on me?

Sometimes this happens, especially during a first experience. We can work with “booster doses” and “parts work” to help you let go of the need for control. Very rarely, some people simply don’t react to a specific medicine. If that happens after several tries, it simply means that isn’t their medicine.

Do I have to “spill my guts” or tell you my secrets?

Not at all. You are still in control of what you choose to share or keep private. If you feel the need to scream or let out big emotions, that is completely okay. In six years of doing this work, we have never seen anyone become seriously aggressive. We are here to stay with you through the fire, no matter how it looks.

Is one journey really enough to fix years of depression or anxiety?

We shouldn’t treat a psychedelic journey like a magic pill that “fixes” everything in six hours. It is more like a massive reset. One experience can often provide more progress than years of talk therapy because it lets you get underneath the mental loops that keep you stuck. It shows you exactly what is possible and where you need to go, but the lasting change comes from the choices you make in your daily life after the retreat. It gives you the chance to change, but you still have to do the work.

Why is this so expensive compared to just buying shrooms on the street?

You aren’t just paying for a substance; you are paying for the environment and the expertise. When you do this alone, you are on your own if things get heavy or if you get stuck in a loop. The cost covers a professional team that knows how to navigate the deep psyche, the medical screening to ensure you are physically safe, and the intense emotional support you receive during the journey. You are paying for a level of safety that allows you to actually let go and do the deep work without being afraid.

What happens the day after? Am I going to be able to drive or go back to work?

The day after a journey, your system is still very sensitive and open. While the physical effects of the medicine are gone, we do not recommend going straight back to work or jumping into high-stress situations. Your nervous system needs time to process what happened. We suggest keeping the following day completely clear, no meetings, no big decisions, and no pressure to “perform.” You need space to just be with yourself while the experience settles into your life.

Who should NOT attend a psychedelic retreat?

People with a history of psychosis, bipolar disorder, serious heart conditions, or those taking certain medications (like SSRIs or MAOIs) should consult a medical professional. Proper screening is essential.

Is psychedelic retreat preparation really necessary?

Yes. Preparation increases emotional safety, reduces risk, and improves the chances of a meaningful and manageable experience.

 

Psilocybin and Psychedelic Therapy FAQ

 

Can doctors prescribe psilocybin?

Generally, no. While Australia and Canada have limited prescribing rights, most countries restrict medical use. However, psilocybin truffles are legal in the Netherlands, use is decriminalized in Portugal, and Oregon and Colorado allow “supported adult use.” The Inner Shift Institute operates legally within these frameworks to ensure safe, compliant journeys.

How does psilocybin affect the brain?

Psilocybin affects the brain by suppressing the Default Mode Network (DMN), or “ego center,” and stimulating neuroplasticity. By activating serotonin 2A receptors, it promotes the release of BDNF, a protein that fosters new neural connections. This process breaks rigid thought patterns and increases cognitive flexibility, enabling deep self-reflection and personal insight.

Who shouldn’t take psilocybin?

Psilocybin is contraindicated for those with psychosis, schizophrenia, or Bipolar. Safety risks are significantly higher for individuals with uncontrolled hypertension, coronary artery disease, or a history of seizures. Use is unsafe with Lithium or certain antidepressants. The Inner Shift Institute utilizes rigorous health screenings to ensure a safe, appropriate fit.

What happens when you take psilocybin every day?

Daily psilocybin use causes rapid tolerance, as brain receptors desensitize to the compound. This often eliminates the desired psychological effects within days. Risks include valvular heart disease from chronic receptor activation and potential psychological strain. Consistent daily use is generally discouraged in favor of “cycling” protocols to maintain efficacy.

What is a psychedelic high like?

A psychedelic high is a profound alteration of consciousness involving visual distortions, synesthesia, and shifted time perception. It is characterized by ego dissolution and intensified emotions due to 5-HT2A receptor activation. The experience is subjective, heavily influenced by “set and setting,” and can range from mystical euphoria to challenging sensory overload.

Is psilocybin toxic to the liver?

No, Psilocybin is not hepatotoxic; it does not cause liver damage. The liver safely converts psilocybin into psilocin, which is then processed and excreted through the kidneys. Toxicity only occurs if poisonous look-alikes (containing amatoxins) are mistakenly consumed. In healthy individuals, psilocybin is physiologically well-tolerated without affecting hepatic function.

Are there negative side effects of psilocybin?

Yes, Psilocybin can cause temporary side effects such as nausea, dizziness, anxiety, confusion, and changes in perception or mood. These effects usually resolve within hours. Rarely, it may worsen anxiety or trigger psychological distress, especially in people with underlying mental health conditions or when used improperly.

Is psilocybin hard on your heart?

No, Psilocybin is not known to cause heart damage. It can temporarily increase heart rate and blood pressure, especially at higher doses. People with cardiovascular disease, arrhythmias, or uncontrolled hypertension should undergo medical screening.

How long do psilocybin effects last?

Psilocybin effects typically last 4 to 6 hours, though experiences can range from 3 to 8 hours depending on dose, individual metabolism, and setting. Effects usually begin within 20 to 60 minutes, peak around 2 to 3 hours, and gradually taper. Mild after-effects or emotional “afterglow” may persist temporarily.

How does psychedelic therapy work?

Psychedelic therapy combines a carefully administered psychedelic substance with structured psychological support. Substances like psilocybin temporarily alter brain connectivity and enhance emotional processing, allowing patients to explore thoughts, memories, and patterns with increased openness. Guided preparation and integration sessions help translate insights into lasting behavioral and mental health improvements.

Is psychedelic therapy legal?

It depends entirely on the country and the substance. Most psychedelics, like psilocybin, LSD, and MDMA, are illegal for recreational use in most places, but some countries or regions allow them legally in a therapeutic context, usually under strict regulation. For example:
United States: Psilocybin therapy is legal in some cities/states like Oregon (with licensed facilitators) and Denver (decriminalized), and MDMA-assisted therapy is in FDA trials for PTSD.
Canada: Psilocybin therapy can be accessed via special exemptions for medical or end-of-life care.
Netherlands: Psilocybin truffles are legal and used in retreats, though “magic mushrooms” are illegal.
Malta: Psilocybin itself is still illegal, but there’s a growing conversation around therapeutic retreats; legality is murky, and it’s often run under exemptions or personal import laws.
“Legal psychedelic therapy” is usually not fully open access. It exists in carefully controlled environments, with trained facilitators, medical oversight, and sometimes special permits.

What are the benefits of psychedelics?

Psychedelics, like psilocybin, can support mental health when used in controlled, therapeutic settings. Research suggests they may reduce symptoms of depression, anxiety, PTSD, and substance use disorders. They can also enhance emotional processing, self-reflection, and creativity. Benefits are maximized under professional guidance with preparation and integration sessions.

What is the most common psychedelic drug?

Psilocybin is the most commonly used psychedelic drug worldwide. It is the active compound in “magic mushrooms” and is widely studied in clinical research for mental health treatment. Its prevalence is driven by historical use, growing medical research, and increasing public awareness.

Do psychedelics cure addiction?

No, Psychedelics do not cure addiction, but clinical research suggests they can support recovery when combined with therapy. Psilocybin, LSD, and ibogaine have shown potential to reduce cravings, enhance emotional processing, and support lasting behavioral change. Effects are strongest under professional guidance with careful preparation, supervised sessions, and post-session integration.

Can psychedelics change your personality?

Yes. Psychedelics can temporarily, and sometimes durably, influence personality traits such as openness, empathy, and emotional flexibility. Clinical studies suggest psilocybin-assisted therapy may support lasting positive changes in mood, perspective, and behavior when combined with preparation, supervised sessions, and integration. Effects vary by individual, dosage, and therapeutic context, and serious or harmful changes are rare in controlled settings.

How much does a psychedelic retreat cost?

Psychedelic retreat costs typically range from $1,000 to $5,000 for 3–7 day programs, depending on location, accommodations, therapy sessions, and included ceremonies. Luxury or specialized retreats may exceed $10,000. Popular destinations include the Netherlands, Costa Rica, and Peru. Always research licensed, reputable providers to ensure safety, integration support, and a high-quality experience.

Are all psychedelic retreats legal?

It depends entirely on the country and substance. In some locations, like the Netherlands, psilocybin truffle retreats are legal under specific regulations, while most psychedelics remain restricted in many other countries. Always confirm local laws, regulatory approvals, and work with licensed, reputable providers to ensure a safe and legal experience.

What is a psychedelic retreat?

A psychedelic retreat is a structured program where participants use psychedelic substances, like psilocybin, under professional guidance for personal growth, emotional insight, or therapeutic support. Retreats typically last 3–7 days and include preparation, guided sessions, integration support, and sometimes ceremonies or workshops. Popular destinations include the Netherlands, Costa Rica, and Peru, with safety and legal compliance prioritized.

Do psychedelics permanently change your brain?

Yes, psychedelics can produce lasting changes in brain function and connectivity, especially when combined with therapy. Research shows that substances like psilocybin can enhance neuroplasticity and support long-term improvements in mood, perspective, and behavior. The extent of change varies by individual, dosage, and therapeutic context, and is generally associated with positive outcomes in guided settings.

Does insurance pay for psychedelic therapy?

No, most insurance plans do not currently cover psychedelic therapy or retreats, as substances like psilocybin remain experimental and are not widely approved for clinical use. Some clinical trials or research programs may provide therapy at reduced cost. Always check with your provider and licensed treatment centers to understand potential coverage or out-of-pocket options.

Is psychedelic therapy safe?

Yes, in controlled clinical settings with trained professionals, psychedelic-assisted therapy is generally safe. Substances like psilocybin temporarily alter perception, heart rate, and blood pressure, but serious adverse effects are rare. Therapy is typically used for depression, PTSD, and anxiety, with sessions lasting several hours and including preparation, guidance, and post-session integration to maximize safety and benefits.

How long is a psychedelic therapy session?

Psychedelic therapy sessions typically last 4 to 8 hours, depending on the substance (psilocybin, LSD, or MDMA), dosage, and therapeutic protocol. Sessions include preparation, guided psychedelic administration, and post-experience integration. Clinical settings provide continuous supervision, and programs often include multiple sessions over days or weeks to maximize safety, insights, and long-term therapeutic benefits.

What are the dark side of psychedelics?

Psychedelics can produce challenging experiences, including anxiety, paranoia, or temporary disorientation, especially at high doses or without guidance. Rarely, they may trigger persistent psychological distress in individuals with pre-existing psychiatric conditions. Clinical settings mitigate these risks with screening, professional supervision, preparation, guided sessions, and integration support, ensuring safety while minimizing adverse effects.

Which psychedelic is best for anxiety?

There is no single “best” psychedelic for anxiety. Clinical research suggests psilocybin-assisted therapy may reduce symptoms of depression and anxiety, especially in patients with treatment-resistant conditions. LSD, MDMA, and other psychedelics are also being studied. Benefits are maximized in supervised, therapeutic settings with preparation and integration, and effects vary by individual and dosage.

What does psilocybin help with?

Psilocybin, when used in supervised therapeutic settings, has shown promise in reducing symptoms of depression, anxiety, PTSD, and substance use disorders. It can also enhance emotional processing, self-reflection, and overall well-being. Benefits are maximized with professional guidance, preparation, guided sessions, and post-session integration, and results vary depending on dosage, individual physiology, and context.

Can psilocybin rewire your brain?

Yes, research indicates that psilocybin can promote neuroplasticity and temporarily alter brain connectivity, supporting changes in mood, perception, and behavior. In therapeutic settings, these neural changes may help reduce symptoms of depression, anxiety, and PTSD. Effects depend on dosage, individual physiology, and integration, and are strongest when combined with professional guidance and structured therapy.

Does psilocybin have permanent effects?

Yes, psilocybin can produce lasting positive effects on mood, perspective, and behavior, especially when used in guided therapeutic settings. Research shows it may promote neuroplasticity and support long-term improvements in emotional processing and well-being. Effects vary by individual, dosage, and therapy context, and serious or harmful long-term effects are rare in supervised clinical programs.

What are the negative effects of psilocybin?

Psilocybin can cause temporary side effects such as anxiety, nausea, headache, dizziness, or perceptual distortions, especially at higher doses or without guidance. Rarely, it may trigger challenging psychological experiences in individuals with pre-existing mental health conditions. Clinical settings mitigate these risks with medical screening, supervised sessions, preparation, and post-experience integration.

Can psilocybin change your personality?

Yes, research indicates psilocybin can produce lasting changes in personality traits such as openness, empathy, and emotional flexibility, particularly when used in guided therapeutic settings. These changes may support improved mood, perspective, and behavior. Effects vary depending on dosage, individual physiology, and integration, and are strongest when combined with preparation, professional guidance, and structured therapy.

Is psilocybin bad for your heart?

No, Psilocybin is generally safe for the heart in supervised, clinical settings. It can temporarily increase heart rate, blood pressure, and occasionally cause mild palpitations, especially at higher doses. Individuals with cardiovascular conditions should undergo medical screening. Continuous monitoring and structured therapy help minimize risk and ensure safe, therapeutic outcomes.

How will I feel after psilocybin therapy?

Most people report feeling calmer, emotionally lighter, and more reflective after psilocybin therapy. Common short-term effects include mental clarity, emotional openness, mild fatigue, or sensitivity. Some experience a positive “afterglow” lasting days to weeks. Responses vary by individual, dosage, and therapeutic support, and integration sessions help process insights and stabilize mood.

Does psilocybin age you?

No, there is no evidence that psilocybin accelerates physical aging. In clinical psilocybin-assisted therapy, it primarily affects brain connectivity, mood, and perception, with temporary physiological changes such as increased heart rate or blood pressure during sessions. Lasting outcomes are typically positive, including improved emotional processing and mental clarity, especially when combined with guided preparation and integration.

Do psychedelics make you more intelligent?

No, Psychedelics do not directly increase intelligence, but research suggests they can enhance creativity, emotional flexibility, and openness, which may improve problem-solving and self-reflection. Effects are temporary and vary by individual, dosage, and setting. Benefits are maximized in guided therapeutic contexts with preparation, supervised sessions, and post-experience integration.

What is the success rate of psychedelic therapy?

Clinical studies show that psilocybin-assisted therapy can produce significant improvements in 50–80% of patients with treatment-resistant depression, anxiety, or PTSD. “Success” typically means meaningful symptom reduction and enhanced emotional processing. Outcomes are strongest when therapy includes preparation, supervised sessions, and post-experience integration. Individual responses and long-term benefits vary depending on dosage, condition, and therapy context.

Do psychedelics really open your mind?

Yes, clinical studies show that psychedelics, such as psilocybin, can enhance cognitive flexibility, emotional openness, and creativity. These changes may help users process emotions, challenge rigid thinking, and gain new perspectives. Effects are strongest in supervised psychedelic-assisted therapy with preparation, guided sessions, and integration. Duration and outcomes vary by dosage, individual physiology, and therapeutic context.

Do psychedelics give you schizophrenia?

No, Psychedelics do not cause schizophrenia in healthy individuals. However, they may trigger or worsen psychotic symptoms in people with a personal or family history of schizophrenia or other psychotic disorders. In supervised clinical settings, careful screening, professional guidance, and structured psychedelic therapy minimize risk and ensure safety.

Do psychedelics make you more self-aware?

Yes, research indicates psychedelics, such as psilocybin, can enhance self-awareness by increasing introspection, emotional processing, and mindfulness. These effects may help users recognize thought patterns, emotions, and behaviors more clearly. Outcomes are strongest in guided psychedelic-assisted therapy with preparation, supervised sessions, and post-experience integration. Effects vary by individual, dosage, and therapeutic context.

Do psychedelics heal trauma?

Yes. Clinical studies show that psychedelics, such as psilocybin or MDMA, can help process trauma-related symptoms by enhancing emotional processing, introspection, and neural connectivity. These benefits are strongest in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-experience integration. Effects vary by individual, dosage, therapy type, and clinical context, and do not “erase” trauma but can support long-term healing.

What is the most therapeutic psychedelic?

Psilocybin is widely considered one of the most therapeutic psychedelics, with clinical studies showing benefits for depression, anxiety, and emotional well-being. MDMA is also studied, primarily for PTSD. Optimal outcomes occur in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-session integration. Effects vary by individual, dosage, condition, and therapy context.

How successful is psychedelic therapy?

Psilocybin-assisted therapy can significantly reduce symptoms of depression, anxiety, and other mood disorders, with 50–80% of patients reporting improvement. Effectiveness is highest in supervised sessions that include preparation, guided administration, and integration. Research indicates outcomes vary based on dosage, individual physiology, and therapy context.

How effective is psilocybin therapy?

Psilocybin therapy is highly effective for many patients with depression, anxiety, and other mood disorders, with improvements reported in 50–80% of cases. Effects are strongest when sessions are supervised and include preparation, guided administration, and integration. Outcomes vary depending on dosage, individual physiology, and therapy context, and research continues to refine best practices.

What are the downsides of psilocybin?

Psilocybin can cause temporary side effects such as anxiety, nausea, headache, dizziness, perceptual changes, and mild increases in heart rate or blood pressure. High doses or unsupervised use may trigger challenging psychological experiences. Individuals with certain mental health conditions are at higher risk. Supervised psilocybin-assisted therapy with preparation, guidance, and post-session integration reduces risks.

What is the healthiest psychedelic?

Psilocybin is often considered one of the safest and healthiest psychedelics when used in supervised therapeutic settings. It shows a low risk of physical toxicity and potential benefits for depression and anxiety. Safety depends on screening, dosage, mental health history, and professional guidance within structured psychedelic-assisted therapy. Individual responses and risks vary.

Can psilocybin cause ego death?

Yes, Psilocybin can cause ego dissolution (“ego death”), a temporary experience of reduced self-boundaries and altered self-perception. Research suggests this effect is dose-dependent and influenced by mindset and setting. It is more likely in guided psychedelic-assisted therapy with preparation and integration. Not everyone experiences ego dissolution, and effects are typically temporary rather than permanent.

Does psilocybin extend your life?

No, there is no evidence that psilocybin directly extends lifespan. However, psilocybin therapy may improve mental health, reduce depression or anxiety, and support healthier behaviors that can indirectly benefit long-term well-being. Benefits are strongest in supervised psychedelic-assisted therapy with preparation and integration. Effects vary by individual, dosage, and health context.

Are psychedelics healthier than alcohol?

Yes, research suggests that psychedelics, such as psilocybin or LSD, have a lower risk of physical toxicity, addiction, and long-term organ damage compared to alcohol. Psychedelics are typically used in controlled, guided settings, while alcohol carries higher risks of dependence, liver disease, and other health issues. Individual effects vary by substance, dose, and context.

Do psychedelics cure depression?

No, Psychedelics, such as psilocybin, do not cure depression, but research shows they can significantly reduce symptoms and improve mood, particularly in treatment-resistant cases. The strongest outcomes occur in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-experience integration. Results vary by individual physiology, dosage, and therapeutic context.

Do psychedelics cure anxiety?

No, Psychedelics, such as psilocybin, do not cure anxiety, but research indicates they can significantly reduce symptoms and improve emotional regulation, particularly in treatment-resistant cases. Benefits are strongest in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-experience integration. Effects are typically temporary and vary depending on individual physiology, dosage, and therapy context.

Do psychedelics cure PTSD?

No. Psychedelics, such as MDMA or psilocybin, do not cure PTSD, but research shows they can significantly reduce symptoms and improve emotional processing, especially in treatment-resistant cases. The strongest outcomes occur in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-session integration. Results vary by individual, dosage, and therapy context.

Can psilocybin rewire your brain?

Yes, research suggests psilocybin can promote neuroplasticity, helping the brain form new connections and pathways. These changes may improve emotional regulation, cognitive flexibility, and behavioral patterns. Effects are most pronounced in supervised psychedelic-assisted therapy with preparation, guided sessions, and post-experience integration. Results vary by individual, dosage, and therapy context.

What are the contraindications for psilocybin therapy?

Psilocybin is generally contraindicated for those with psychosis, schizophrenia, or Bipolar. Safety risks are significantly higher for individuals with uncontrolled hypertension, coronary artery disease, or a history of seizures. Use is unsafe with Lithium or certain antidepressants. The Inner Shift Institute utilizes rigorous health screenings to ensure a safe, appropriate fit.

What are the criticisms of psychedelic therapy?

Studies suggest criticisms of psychedelic therapy include limited long-term research, high cost and access barriers, and the potential for intense experiences that may feel emotionally destabilizing. Psychological risks such as anxiety or distress can occur. While psilocybin and MDMA show promise, supervised psychedelic-assisted therapy with screening, preparation, and integration is essential to reduce risks and support safe outcomes.

Can you get PTSD from psychedelics?

No, Psychedelics, such as psilocybin or LSD, do not cause PTSD in healthy individuals. However, intense or challenging experiences, especially in unsupervised settings or at high doses, can trigger temporary anxiety, panic, or exacerbate pre-existing mental health conditions. Supervised psychedelic-assisted therapy with preparation, guidance, and integration minimizes these risks and supports safe outcomes.

What is the success rate of psychedelic therapy?

Psychedelic therapy success rates significantly outperform traditional SSRIs. Clinical trials show a 67-71% success rate for PTSD and a 71-75% response rate for depression, with over 50% achieving long-term remission. The FDA recognizes these as “Breakthrough Therapies,” though success requires guided integration sessions alongside the dosing.

Is psilocybin good for ADHD?

Yes, psilocybin is a major focus of current ADHD research due to its ability to enhance neuroplasticity and emotional regulation. Studies suggest it can “rewire” the brain’s Default Mode Network (DMN), which is typically overactive in those with ADHD.


Ready for Your Inner Shift? ✨

Find out more about our psilocybin assisted therapy sessions and psilocybin assisted retreat.

Alice Smeets, IFS practitioner, founder of the Inner Shift Institute

About The Author

Alice Smeets
Alice Smeets is the founder of the Inner Shift Institute. She is an IFS practitioner and somatic process worker trained by David Bedrick at the Santa Fe Institute for Shame Based Studies, with more than six years of experience guiding legal psychedelic therapy retreats. She writes about psychedelics, shame, and the subconscious mind.